Cannabis Science Conference Spring 2024: Pre-Conference Workshops
Analytical Track Program Chair Julie Kowalski discusses details from the four preconference workshops.
Taking place May 7–9, 2024, in Kansas City, Missouri, Cannabis Science Conference is the premier cannabis science conference focusing on analytical science, medical cannabis, cultivation, and compliance. Listen as Julie Kowalski, Chair for the Analytical Track and the Director of Technical Programming, shares what she is excited to see in the four pre-conference workshops! View the full agenda and start planning your conference experience here.
Cannabis Science Conference Spring 2024 Pre-Conference Workshops:
- Cannabis Nursing: A Paradigm Shift in Healthcare
- Microbiology 101: So Easy, Anyone Can Do It
- ASTM Sub-Committee Meetings
- Turn Mountains into Molehills: Cannabis Science Advice and Troubleshooting with Cannabis Experts
Get a sneak peek into the workshops, read the transcription below, and register here for Cannabis Science Conference Spring 2024!
Read what Analytical Program Chair Julie Kowalski says about the workshops:
Julie Kowalski: One is going to be some medical type training for nurses. There's going to be a full day dedicated to that. And it's Nurses Week, so we're really excited to have them on board.
We also have a great course that was put together specifically for this conference and for this audience, pulling from different suppliers and we have participation from a cannabis testing lab. It’s Microbiology 101, which for a lot of laboratories, and even growers and producer processors, really understanding the fundamentals of microbiology testing. It's going to be awesome, because first of all, they're a really fun group and hilarious—I've been on meetings with them. But also it's going to be hands on, so you're going to be able to learn some skills that are really critical to ensuring that your results are correct. This would be a great workshop for people that maybe want to do some in-house testing, or just want to understand when they send their samples out to a laboratory, what that lab is doing and get a better handle on it. For labs and their staff, I know, as a chemist myself, there's a little bit of a mind shift when you're doing microbiology testing; you have to be a little bit more aware of being clean and contamination and things like that. So I think it's going to be really a great training course. I'm so excited for it.
Then we have ASTM, which is doing a lot of work in the standards realm helping to build standards for the cannabis industry. They are going to run about four hours of meetings. So they'll have four one-hour meetings that are going to be based around different standards that they're building. So check out information on that. It’s free to attend and you don't have to be a member of ASTM. So go check out what they're doing and participate in that. That helps the industry as a whole.
The final thing is in the afternoon, myself and a few other people are going to host Turning Mountains into Molehills, which is a little bit more of an open discussion. So just everyone getting in a room no matter what sector you're from—we have experience from chemistry and microbiology, legislation, and standards. So we have a the host and a range of expertise and we're going to ask for questions in advance. So this is your chance to really be in a room with experts and other people in the same position as you, try to figure out how we're all navigating, get advice, and offer your own advice.
Cannabis, US Presidential Election 2024, and Beyond: A Roundtable Discussion, Part II
December 17th 2024With the recent 2024 presidential election behind us, the future of cannabis still has many unknowns moving forward and questions still to be discussed. In this roundtable discussion with four knowledgeable industry leaders, we explore the nuanced political landscape of cannabis legalization and rescheduling in the context of the election, including state and federal policies and possible paths forward for testing standardization. Join us in the second part of a compilation of responses from Kim Anzarut, CQA, CP-FS, CEO of Allay Consulting; Susan Audino, PhD, founder of S.A. Audino & Associates, LLC; Zacariah Hildenbrand, PhD, research Professor at the University of Texas at El Paso; and David Vaillencourt, CEO of The GMP Collective.
Cannabis, US Presidential Election 2024, and Beyond: A Roundtable Discussion, Part I
December 16th 2024With the recent 2024 presidential election behind us, the future of cannabis still has many unknowns moving forward and questions still to be discussed. In this roundtable discussion with four knowledgeable industry leaders, we explore the nuanced political landscape of cannabis legalization and rescheduling in the context of the election. We discuss what drives support or opposition from both sides of the aisle, the complexities of balancing state and federal priorities, and more. Join us in the first part of a compilation of responses from Kim Anzarut, CQA, CP-FS, CEO of Allay Consulting; Susan Audino, PhD, founder of S.A. Audino & Associates, LLC; Zacariah Hildenbrand, PhD, research Professor at the University of Texas at El Paso; and David Vaillencourt, CEO of The GMP Collective.
Empowering Women in Cannabis: Susan Audino, PhD, on Inclusivity, Integrity, and Industry Challenges
December 11th 2024Founder of S. A. Audino & Associates, LLC, Susan Audino, PhD, recently co-founded Saturn Scientific, LLC, a collaboration of five experienced individuals providing unbiased evaluations on the data and science for stakeholders in the cannabis industry. In this interview with Cannabis Science and Technology, Dr. Audino shares her unexpected path into analytical science and the cannabis industry as well as the obstacles she’s faced throughout her career. She highlights the gender bias she’s observed, such as unequal recognition of credentials and workplace challenges, while advocating for inclusivity and mentorship to empower women in science. Additionally, Dr. Audino recounts her experiences of navigating the male-dominated cannabis space, pushing for transparency, collaboration, and integrity in laboratory practices. Ultimately, Audino believes fostering mutual respect and knowledge-sharing is vital for the industry’s growth and resilience.
Collaboration, Gender Diversity, and Progress: Julie Kowalski on Advancing Cannabis Science
December 10th 2024In this interview with Cannabis Science and Technology, Julie Kowalski, an experienced analytical chemist, discusses her path into the cannabis industry, starting with early work in gas chromatography. Kowalski reflects on her perspectives as a female scientist, highlighting biases she’s experienced and the benefits of gender inclusivity in the cannabis space. Greater unity and professionalism could benefit the industry as a whole, she explains. She also encourages collaboration and more women in leadership positions in order to build a stronger scientific community, and also urges women to advocate for themselves, noting that women in cannabis face unique obstacles but often demonstrate consensus-building strategies and solutions.
Gender Diversity and Innovation in the Cannabis Space: Insights from Tess Eidem, PhD
December 9th 2024Cannabis Science and Technology sat down with Tess Eidem, PhD, PCQI, member of Saturn Scientific, LLC, to discuss her journey from antibiotic research to cannabis microbiology and her observations throughout her career. Dr. Eidem highlights challenges women face in this male-dominated industry, including limited representation in leadership roles and frequent experiences of bias and discrimination. She emphasizes the importance of gender diversity in fostering innovation, improving product safety, and addressing women’s health needs in cannabis applications. Her advice to women scientists is to build strong professional relationships and carefully evaluate work environments to advance their careers in this evolving and often challenging space.
Inside the University of Maryland School of Pharmacy’s Graduate Program in Medical Cannabis
September 16th 2024Leah Sera, PharmD, MA, the co-program director for the University of Maryland School of Pharmacy’s Graduate Studies in Medical Cannabis program sat down with Cannabis Science and Technology to discuss higher education in medical cannabis.
